Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
about
Patterns of brain injury in inborn errors of metabolismBrain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.Pathways of Amino Acid Degradation in Nilaparvata lugens (Stål) with Special Reference to Lysine-Ketoglutarate Reductase/Saccharopine Dehydrogenase (LKR/SDH).Developmental Defects of Caenorhabditis elegans Lacking Branched-chain α-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency.Biochemical correlates of neuropsychiatric illness in maple syrup urine diseaseDual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseTherapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy.Adherence issues in inherited metabolic disorders treated by low natural protein diets.The neuropsychiatry of inborn errors of metabolism.Neurocognitive profiles in MSUD school-age patients.Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.Structural white matter changes in adolescents and young adults with maple syrup urine disease.Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease.Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.Disorders of branched chain amino acid metabolism.
P2860
Q26825171-3259C33E-324B-4CAC-ACBB-59EA9E835F02Q33617530-FED844AE-1DBA-420E-B069-3ECC07F959D6Q33947369-B9BBBA08-5CDB-4DC7-B30D-6B6864B62656Q35637264-2D2691D8-2B50-49F6-B888-33E08E5EB05BQ36548413-3CAAF865-CFA9-43EC-9735-4B77C33A4D14Q36733516-59BB0047-4A9E-4152-A987-83EC55122088Q37158185-14B80B2F-1B36-4D8E-9C87-487BFEEE49D4Q37684677-26891A4B-C0DD-4E57-B8E8-B25580C36A55Q37871909-D21EEE85-044F-4D00-8D01-1A8525E811EAQ38064765-53D1A1A3-DFB2-4442-8B81-066486F0A98EQ38108763-1C2A50E0-4929-43BD-9844-018758A0D129Q38890001-BC4782C3-911C-4374-AD75-CB066C74EA1DQ39359596-564DD7D4-B4E1-447D-944E-8C6DBED8236FQ40300205-887239AC-BE80-4E49-90EA-5601A1C7C3BCQ40364430-A5C26E3A-ECEE-4BFC-9413-56BBB8F97FEDQ40909680-97D00458-B565-4279-B3E7-295F1DFBA1C5Q41477074-70B6E0B9-D9C7-4B5F-B243-333A2E7EE06BQ41699171-D3BDD9F5-6C15-4905-B734-D2C5D1ECC84DQ44802736-87EFCC30-8E5B-44AD-9EEA-3A29DAE8FD84Q46530247-1B63A266-E453-4D04-9704-ADEFBF3AAA9FQ47694590-8AF5013C-52FB-47F5-9236-0F84FB4DA75CQ48099910-CB7AB115-15C2-4E01-B93B-65A717ABBF96Q48329474-9FA01FCB-13AF-4D8F-95F3-9536B0083086Q48578226-624C4CF9-63B3-40E7-ADB4-F1F4E0BE2C52Q48663430-5BF792EB-159F-451B-8F78-A4506AB204C3Q50581992-3970FCF1-DCBF-430C-A819-A1F876480A42Q54966951-EF664F09-6E1B-43F5-9299-D8333968816F
P2860
Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@ast
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@en
type
label
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@ast
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@en
prefLabel
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@ast
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@en
P2093
P1476
Dysmyelination in the brain of ...... ith maple syrup urine disease.
@en
P2093
Schweiger B
Schönberger S
P356
10.1016/J.YMGME.2004.01.016
P577
2004-05-01T00:00:00Z